(ARRY) Array Biopharma complete technical analysis [charts+indicators] | Buy/Sell Array Biopharma | (ARRY) share price targets
Complete technical analysis of Array Biopharma (ARRY) by charts plus indicators, forecast predictions and share price targets for Array Biopharma (ARRY)
Array Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-15 View latest technical analysis
10 day averaged volume of Array Biopharma is 4889350
| Date | Daily Closing Price | Open | High | Low | Volume |
| 15 Tue Oct 2024 | 7.06 | 6.61 | 7.07 | 6.60 | 1.236 times |
| 14 Mon Oct 2024 | 6.73 | 7.10 | 7.13 | 6.67 | 0.96 times |
| 11 Fri Oct 2024 | 7.16 | 6.48 | 7.19 | 6.47 | 1.241 times |
| 10 Thu Oct 2024 | 6.52 | 6.64 | 6.72 | 6.43 | 1.279 times |
| 09 Wed Oct 2024 | 6.91 | 6.47 | 7.15 | 6.44 | 1.276 times |
| 08 Tue Oct 2024 | 6.44 | 6.40 | 6.57 | 6.23 | 1.02 times |
| 07 Mon Oct 2024 | 6.46 | 6.46 | 6.75 | 6.35 | 0.662 times |
| 04 Fri Oct 2024 | 6.45 | 6.48 | 6.54 | 6.27 | 0.884 times |
| 03 Thu Oct 2024 | 6.32 | 6.38 | 6.51 | 6.25 | 0.564 times |
| 02 Wed Oct 2024 | 6.41 | 6.74 | 6.74 | 6.30 | 0.88 times |
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 7.2, for a target of 6.8 or 6.58
Share price targets for Array Biopharma (ARRY)
| Target Type | Value |
| Downside Target | 5.56 |
| Downside Target | 6.04 |
| Downside Target | 6.23 |
| Downside Target | 6.60 |
| Downside Target | 6.81 |
| Downside Target | 6.95 |
| Upside Target | 7.13 |
| Upside Target | 7.47 |
| Upside Target | 9.34 |
| Upside Target | 10.05 |
| Upside Target | 10.79 |
| Upside Target | 12.06 |
| Upside Target | 14.45 |
Intraday share price targets for Array Biopharma (ARRY)
| Target Type | Value |
| Downside Intraday Target | 6.73 |
| Downside Intraday Target | 6.4 |
| Upside Intraday Target | 7.26 |
| Upside Intraday Target | 7.46 |
| Downside Intraday Target | 6.93 |
Weekly technical analysis of Array Biopharma (ARRY)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 15 Tue Oct 2024 | 7.06 | 7.10 | 7.13 | 6.60 | 0.401 times |
| 11 Fri Oct 2024 | 7.16 | 6.46 | 7.19 | 6.23 | 1.305 times |
| 04 Fri Oct 2024 | 6.45 | 6.61 | 6.81 | 6.25 | 1.06 times |
| 27 Fri Sep 2024 | 6.73 | 6.48 | 6.95 | 6.04 | 0.685 times |
| 20 Fri Sep 2024 | 6.41 | 6.86 | 7.47 | 6.31 | 0.748 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Array Biopharma (ARRY)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 15 Tue Oct 2024 | 7.06 | 6.60 | 7.19 | 6.23 | 0.495 times |
| 30 Mon Sep 2024 | 6.60 | 6.66 | 7.47 | 5.56 | 0.7 times |
| 30 Fri Aug 2024 | 6.71 | 10.50 | 10.79 | 6.25 | 1.404 times |
| 31 Wed Jul 2024 | 10.52 | 10.43 | 12.06 | 9.34 | 1.233 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Array Biopharma (ARRY)
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Array Biopharma stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Array Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Array Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.7 and Array Biopharma (ARRY) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Array Biopharma ( (ARRY) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Array Biopharma stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Array Biopharma in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Array Biopharma Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Array Biopharma in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Array Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 6.7 and Array Biopharma (ARRY) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Array Biopharma (ARRY) stock. Volume based technical analysis of Array Biopharma (ARRY) stock is negative.
Array Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.